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Letters to the
Editor
Stroke prevention by means of
epicardial occlusion of the left atrial
appendage
To the Editor:
With great interest we read the article by
Kamohara and colleagues1 about a novel
device for left atrial appendage (LAA) oc-
clusion. The atrial exclusion device was
applied by means of thoracotomy in 8 mon-
grel dogs and was evaluated between 7 and
90 days by using echocardiography, left
atrial angiography, histologic inspection,
and gross pathology.
The main criticism regarding the study is
the low number of investigated subjects and
the lack of a control group. No statistical con-
clusions can be drawn from such a small
series.
The follow-up period was extremely short
regarding hemodynamic consequences of
LAA occlusion, tolerability of the applied
material, and mechanical stability of the device.
It would be of interest to know whether
hemodynamic studies were performed dur-
ing cardiac cathetherization to assess the
influence of LAA occlusion on left atrial
compliance and cardiac output.2
It is known that in human subjects LAA
size varies extremely and that LAAs tend
to be larger in patients with atrial fibrilla-
tion than in patients with sinus rhythm.3
Did the authors also investigate dogs with
atrial fibrillation, and what was the size of
the occluded LAAs?
The LAA is known as a place of na-
triuretic peptide secretion.2 Were serum
levels of natriuretic peptides measured
during the procedure and follow-up? Did
the authors observe weight gain caused
by fluid retention after LAA occlusion?
Did the dogs show any clinical signs of
heart failure, changes in heart rate and
blood pressure, and electrocardiographic
changes during follow-up after LAA oc-
clusion?
It has been shown in sheep that LAA
destruction leads to reduced thirst in hy-
povolemia.4 Did the authors observe a
similar effect in the investigated dogs?
Were troponin and creatine kinase lev-
els measured after the intervention? Be-
cause of the proximity of the circumflex
branch of the left coronary artery to the
LAA base, the coronary artery might have
been affected.
Even though the occlusion rate by the
atrial exclusion device seems higher than
that in previously reported surgical and
interventional procedures, there is still no
evidence that this procedure will prevent
cardiac thrombus formation outside the
LAA and thus prevent stroke in atrial fibril-
lation. Furthermore, there is evidence that left
atrial and appendage thrombi, as detected
with transesophageal echocardiography
(TEE), are not significant predictors for sub-
sequent stroke or embolism.5 Additionally,
there are no studies that show convincingly
that LAA occlusion with any device or sur-
gical technique has prevented strokes.
In conclusion, the value of LAA oc-
clusion to prevent stroke or embolism
remains questionable. The LAA, how-
ever, plays an important role in regulat-
ing hemodynamics, as well as water and
sodium hemostasis. As long as the phys-
iologic function of the LAA in human
subjects is not completely clarified, it remains
unknown whether LAA elimination, by what-
ever means, is beneficial or harmful.
Claudia Stöllberger, MDa
Birke Schneider, MDb
Josef Finsterer, MDc
Krankenanstalt Rudolfstiftunga
2. Medizinische Abteilung
Juchgasse 25
A-1030 Wien, Österreich
E-mail: claudia.stoellberger@chello.at
Klinik für Kardiologieb
Städtisches Krankenhaus Süd
Lübeck, Germany
Krankenanstalt Rudolfstiftungc
Wien, Österreich
References
1. Kamohara K, Fukamachi K, Ootaki Y,
Akiyama M, Zahr F, Kopcak MW, et al.
A novel device for left atrial appendage ex-
The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 1 207
clusion. J Thorac Cardiovasc Surg. 2005;
130:1639-44.
2. Stöllberger C, Schneider B, Finsterer J. Elim-
ination of the left atrial appendage to prevent
stroke or embolism? Anatomic, physiologic,
and pathophysiologic considerations. Chest.
2003;124:2356-62.
3. Ernst G, Stöllberger C, Abzieher F, Veit-Dirscherl
W, Bonner E, Bibus B, et al. Morphology of the
left atrial appendage. Anat Rec. 1995;242:553-61.
4. Zimmermann MB, Blaine EH. Water intake
inhypovolemic sheep: effects of crushing
the left atrial appendage. Science. 1981;211:
489-91.
5. Stöllberger C, Chnupa P, Kronik G, Brainin M,
Finsterer J, Schneider B, et al. Transesophageal
echocardiography to assess embolic risk in pa-
tients with atrial fibrillation. Ann Intern Med.
1998;128:630-8.
doi:10.1016/j.jtcvs.2006.02.027
Reply to the Editor:
We appreciate the response by Stöllberger,
Schneider, and Finsterer to our work1 and
thank them for their valuable comments.
As they mentioned, this series in dogs
was too small to confirm the long-term
safety and tissue response to the atrial ex-
clusion device (AED). However, the main
purpose of this series was to assess the
feasibility of the device implant during a
beating heart procedure, and thus we did
not include a control group or an atrial
fibrillation (AF) animal model, which
would have been helpful to evaluate the
safety and efficacy of this device.
Because of the main goal of this study
series, we also did not analyze biochemis-
try levels such as serum natriuretic peptide,
troponin, and creatine kinase, nor did we
obtain hemodynamic data derived from car-
diac catheterization with the exception of
left atrial (LA) pressure, heart rate, and sys-
temic arterial pressure. However, we per-
formed echocardiographic evaluations at
baseline, after AED implant, and at follow-
up. The pulmonary venous flow, transmi-
tral flow, and tissue Doppler imaging of the
mitral annular motion, which provide addi-
tional information regarding atrial and ven-
tricular filling and function,2,3 were evalu-
ated to assess the influence of left atrial
appendage (LAA) exclusion on LA func-
tion. The Doppler pulmonary venous flow
data suggested that LAA exclusion may af-
fect LA reservoir function without affect-
ing left ventricular diastolic function. After
we obtain echocardiographic data from our
next series of animals, we intend to report
more detailed echocardiographic evalua-
tion results in the near future.
With respect to the effect of device im-
plant on flow through the left circumflex ar-
tery, although specific evaluations including
coronary angiography and left circumflex
flow measurement with a flow probe were
not performed in this series, no macroscopic
findings of myocardial infarction at explant
surgery or gross examination were found.
As also mentioned, LAA exclusion may
cause adverse effects due to lack of serum
natriuretic peptide. In this series, there
were no clinical signs of heart failure, in-
cluding general fatigue or significant
changes in the weights and heart rates of
any dog, throughout the study.
To date, there have been no reports show-
ing clear evidence of a role of LAA exclusion
on stroke prevention for patients with non-
valvular AF. However, considering that LA
thrombi in more than 90% of cases of non-
valvular AF are located in the LAA4 and
surgical LAA ligation or excision does not
appear to have clinically important deleteri-
ous effects according to extensive study on
the Maze procedure by Cox and associates,5
LAA exclusion should be considered one of
the most important therapeutic options, espe-
cially for patients with AF who are not eligi-
ble for any anticoagulation therapy.
We agree with the potential concerns
related to hemodynamic and neurohumoral
consequences after LAA exclusion. In prep-
aration for a clinical AED application, fur-
ther evaluations using both a control and
AF animal model will definitely be required
to address the following points: (1) compe-
tency of LAA exclusion with various LAA
sizes, (2) long-term stability of the AED,
(3) potential LA thrombus formation due
to the device implant in an AF model,
and (4) neurohumoral effects of LAA ex-
clusion. We hope these further evaluations
will provide us with clearer information
that elucidates the exact role of LAA ex-
clusion.
We continue to work on this subject and
look forward to publishing more informa-
tion on the AED, the implantation proce-
dure for LAA exclusion, and its effects on
physiologic function.
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Is it really the number of clamps that
is responsible for worse postbypass
neurological outcomes?
To the Editor:
I read with interest the article by Dr Hammon
and colleagues1 comparing varying levels of
aortic manipulation in bypass surgery with
regard to postoperative neurobehavioral out-
comes. Even as the results are in some con-
currence with certain previous trials in this
direction, I do believe that this report re-
quires careful review before its recommen-
dations can be accepted.
First, the multiple aortic clamping group
had greater age, incidence of hyperlipid-
emia, and aortic fibrillation than the single
aortic clamping group, 3 independent pre-
dictors of postoperative stroke.2 Second,
the authors were unable to demonstrate any
significantly worse result in the 2 groups,
apart from the neuropsychologic deficit at
6-month follow-up. Recent prospective
neuropsychologic testing indicates that
these late neurocognitive deficits are likely
to be caused by established risk factors for
cerebral vasculopathy not having anything
to do with the bypass procedure itself.3
It is therefore arguable that the mere
reduction in the number of clamps would
have a significant effect on patient neuro-
logical profile after bypass surgery, consid-
ering that there exists already conflicting
evidence, with no additional benefit of re-
duction in clamp number being recorded
previously.4 Consensus in the literature has
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